dcsign
homolog
lsign
also
call
dcsignr
belong
ctype
calciumdepend
lectin
famili
larg
group
protein
includ
mannos
receptor
langerin
special
recognit
carbohydr
structur
present
cellular
viral
protein
implic
sever
process
cell
adhes
antigen
present
dcsign
lsign
constitut
express
specif
cell
popul
play
key
role
activ
innat
adapt
immun
respons
dcsign
highli
express
surfac
dendrit
cell
dc
local
lymphoid
tissu
thymu
tonsil
lymph
node
mucos
surfac
dermi
dcsign
express
langerhan
cell
uniqu
dc
subset
resid
epidermi
certain
macrophag
hofbauer
cell
placenta
kupffer
cell
liver
sinusoid
alveolar
macrophag
shown
express
dcsign
lsign
express
restrict
endotheli
cell
lymph
node
placenta
particularli
liver
sinusoid
endotheli
cell
lsec
dcsign
lsign
share
nearli
amino
acid
ident
close
relat
global
architectur
lectin
type
ii
transmembran
protein
compos
short
cytoplasm
tail
respons
signal
intern
transmembran
region
neck
domain
consist
eight
repeat
region
amino
acid
carbohydr
recognit
domain
crd
bind
carbohydr
ligand
calciumdepend
manner
fig
dcsign
crd
recogn
differ
mannos
fucosebas
carbohydr
wherea
lsign
crd
appear
interact
mannos
residu
nglycan
repeat
region
within
neck
domain
permit
oligomer
lectin
critic
biolog
activ
tetram
effici
captur
glycosyl
ligand
dcsign
origin
clone
abil
bind
intern
heavili
glycosyl
human
immunodefici
viru
hiv
protein
dcsign
strongli
bind
hiv
simian
immunodefici
viru
siv
strain
examin
date
play
import
role
viru
adhes
dc
studi
pave
way
investig
interact
dcsign
pathogen
becom
clear
mani
virus
target
dcsign
lsign
bind
dc
endotheli
cell
respect
lectin
recogn
high
mannos
oligosaccharid
present
viral
glycoprotein
thu
function
attach
factor
sever
virus
includ
cytomegaloviru
cmv
dengu
dv
ebola
sever
acut
respiratori
syndrom
sar
hepat
c
hcv
marburg
sindbi
virus
tabl
differenti
glycosyl
viral
envelop
glycoprotein
strongli
influenc
effici
viral
captur
dcsign
lsign
exampl
dv
envelop
glycoprotein
e
two
conserv
nlink
glycosyl
site
mediat
dv
bind
dc
mannosyl
e
glycoprotein
expos
surfac
dv
virion
transmit
human
infect
mosquito
e
protein
complex
glycosyl
produc
mammalian
cell
shown
interact
dcsignexpress
cell
dcsign
lsign
endocyt
receptor
cytoplasm
tail
carri
put
internalis
signal
dileucin
motif
present
dcsign
lsign
triacid
cluster
believ
involv
intracellular
traffick
fig
despit
find
show
larg
fraction
viral
particl
captur
dcsign
rapidli
intern
degrad
virus
nevertheless
abl
hijack
dcsign
lsign
function
spread
infect
virus
examin
date
dcsign
lsign
shown
act
attach
factor
rather
authent
entri
receptor
involv
membran
fusion
exclud
possibl
virus
particularli
requir
target
acidifi
endosom
membran
fusion
use
lectin
primari
entri
receptor
dcsign
lsign
also
shown
function
cisreceptor
enhanc
infect
target
cell
mechan
known
cisinfect
describ
dv
cmv
hiv
probabl
reli
capac
lectin
concentr
viral
particl
cell
surfac
allow
optim
interact
cognat
receptor
enhanc
viral
entri
tabl
virus
captur
dcsign
lsign
also
transmit
tran
target
cell
express
entri
receptor
transinfect
propos
hiv
hcv
sar
viru
hiv
cmv
dcsign
enhanc
infect
target
cell
low
multipl
infect
moi
dcsignbound
virus
infect
target
cell
effici
free
virus
remain
infecti
sever
day
molecular
mechan
underli
process
remain
poorli
understood
contribut
dcsign
lsign
viral
transmiss
dissemin
vivo
current
unknown
role
princip
attach
factor
broad
rang
envelop
virus
restrict
express
anatom
site
viru
exposur
suggest
two
lectin
dictat
viral
tropism
dc
endotheli
cell
consequ
may
influenc
viral
pathogenesi
dc
sentinel
cell
captur
pathogen
enter
skin
mucos
tissu
migrat
lymph
node
present
process
antigen
tcell
initi
adapt
immun
respons
interact
dcsign
virus
transmit
sexual
hiv
introduct
human
skin
insect
vector
dengu
viru
sindbi
viru
may
hijack
dc
function
either
modul
immun
respons
assur
dissemin
peripher
tissu
lymphoid
organ
lsec
also
particip
captur
process
foreign
antigen
addit
elimin
undesir
macromolecul
blood
transport
hepatocyt
lsec
repres
barrier
separ
liver
blood
could
exploit
virus
hcv
order
gain
access
hepatocyt
recommend
two
follow
review
overview
physiolog
import
lsec
viral
infect
liver
chapter
provid
gener
protocol
studi
molecular
interact
virus
dcsign
lsign
investig
function
two
lectin
viral
infect
transmiss
first
describ
method
use
obtain
human
dermallik
dc
cell
express
dcsign
lsign
next
present
protocol
produc
solubl
viral
envelop
protein
use
semliki
forest
viru
sfv
vector
studi
molecular
basi
viral
captur
intern
dcsign
lsign
final
describ
method
requir
assess
contribut
dcsign
lsign
ci
transinfect
product
use
cell
cultur
purchas
invitrogen
rpmi
glasgow
modifi
eagl
medium
gmem
fetal
calf
serum
fc
penicillinstreptomycin
hepe
tryptos
phosphat
broth
except
cysteinemethioninefre
dulbecco
modifi
eagl
medium
dmem
icn
biomed
phycoerythrin
pe
conjug
mous
monoclon
antibodi
mab
direct
dcsign
lsign
lectin
purchas
r
system
antidcsign
mab
clone
develop
laboratori
previous
describ
antidcsign
direct
crd
inhibit
dcsign
activ
direct
lectin
purchas
r
system
block
activ
lectin
differenti
human
dc
assess
fluorescenceactiv
cell
sort
fac
analysi
use
fluorescein
isothiocyan
fitc
conjug
mous
mab
purchas
bd
bioscienceshela
cell
maintain
dmem
supplement
fc
antibiot
streptomycin
penicillin
raji
cell
grown
rpmi
contain
fc
antibiot
bhk
cultur
gmem
fc
penicillinstreptomycin
mm
hepe
tryptos
phosphat
brothcel
line
express
dcsign
lsign
gener
transduct
retrovir
trip
vector
gift
pierr
charneau
pasteur
institut
franc
encod
either
dcsign
lsign
transduc
cell
stain
peconjug
antidcsign
mab
sort
high
express
level
dcsign
lsign
human
peripher
blood
mononuclear
cell
pbmc
isol
healthi
donor
densiti
gradient
centrifug
ficollpaqu
plu
amersham
bioscienc
lysi
buffer
dissolv
g
g
l
water
complement
ml
edta
mm
ph
lysi
buffer
must
autoclav
store
sever
monthsmac
buffer
phosphatebuff
salin
pb
contain
mm
edta
ph
bovin
serum
albumin
bsa
sigma
aldrich
buffer
kept
sever
monthsfilt
cell
strainer
use
elimin
cell
aggreg
purchas
falconmonocyt
neg
select
use
fcr
block
biotin
antibodi
ab
cocktail
antibiotin
magnet
bead
miltenyi
biotec
recombin
human
interleukin
il
recombin
human
granulocytemacrophag
colonystimul
factor
gmcsf
purchas
peprotech
gentaur
respect
solubl
viral
glycoprotein
produc
use
sfv
vector
bhk
mammalian
cell
sfv
shut
cellular
translat
machineri
transduc
cell
produc
viral
protein
interest
secret
accumul
supernat
infect
cell
allow
product
larg
amount
solubl
protein
high
degre
puriti
sfv
express
vector
origin
describ
review
briefli
sfv
genom
singlestrand
posit
rna
encod
structur
nonstructur
viral
protein
signal
sequenc
rna
domain
permit
specif
viral
genom
packag
sfv
vector
made
two
cdna
fig
first
code
sfv
rna
genom
sequenc
correspond
structur
protein
replac
solubl
glycoprotein
interest
structur
protein
encod
second
cdna
lack
packag
signal
cdna
transcrib
vitro
transfect
cell
electropor
way
rna
encod
protein
interest
packag
new
defect
viral
particl
sfv
envelop
protein
activ
furin
cleavag
golgi
apparatu
replac
furin
site
chymotrypsin
site
allow
control
sfv
particl
previous
describ
polymeras
chain
reaction
pcr
fragment
code
solubl
glycoprotein
interest
usual
digest
either
bssh
ii
nsi
bssh
ii
apa
bamh
introduc
restrict
enzym
spe
sph
purchas
new
england
biolab
dna
purif
kit
qiaquick
pcr
purif
kit
purchas
rna
polymeras
rnasin
purchas
roch
appli
scienc
promega
electropor
cuvet
purchas
eurogentectn
buffer
mm
trishcl
nacl
edta
ph
prepar
distil
water
store
sever
monthschymotrypsin
aprotinin
purchas
sigma
aldrichperoxidaseconjug
mab
diaminobenzidin
dab
solut
kit
obtain
vector
laboratori
abci
biologi
dab
solut
prepar
ad
four
drop
dab
solut
two
drop
solut
two
drop
nickel
solut
two
drop
buffer
solut
ml
water
cystein
methionin
promix
obtain
amersham
hydrochlorid
dmj
swainsonin
purchas
calbiochem
sigma
respect
molecul
specif
inhibit
ii
permit
product
protein
mannos
carbohydr
residu
mammalian
cell
fig
glycoprotein
concentr
column
biomax
millipor
appropri
molecular
weight
cutoff
particular
protein
producedendoglycosidas
h
endoh
peptid
nglycosidas
f
pngase
f
purchas
roch
appli
scienc
new
england
biolab
respect
buffer
provid
pngase
f
use
treat
glycoprotein
either
endoh
pngase
f
pngase
f
abl
digest
nglycan
wherea
endoh
digest
nglycan
unmodifi
ii
fig
buffer
pb
contain
bsa
sodium
azid
mm
mm
buffer
store
sever
monthsbuff
b
serumfre
rpmi
contain
mm
mm
buffer
b
store
monthsmannan
edta
ph
egta
ph
purchas
sigma
aldrich
mannan
stock
solut
dissolv
water
store
sever
monthsscintil
solut
obtain
wallac
optiphas
supermix
solut
wildtyp
virus
viral
particl
carri
report
gene
firefli
luciferas
luc
green
fluoresc
protein
gfp
use
studi
dcsign
lsignmedi
cisinfect
transenhanc
target
cell
infect
virus
prepar
use
standard
method
exampl
describ
note
fresh
blood
ml
complet
ml
pbsprepar
tube
contain
ml
ficol
slowli
add
ml
blood
tube
take
care
avoid
mix
centrifug
min
without
brake
room
temperatureaspir
plasma
transfer
pbmc
white
ring
new
tube
contain
ml
pb
two
ring
per
tube
complet
tube
ml
pb
centrifug
min
room
temperatur
repeat
wash
step
twice
time
pool
two
tubesremov
supernat
resuspend
pellet
ml
lysi
buffer
min
add
ml
pb
fc
centrifug
min
resuspend
pellet
ml
cold
mac
buffer
isol
pbmc
pass
filter
place
insid
tube
elimin
cell
aggreg
filter
rins
twice
ml
mac
buffer
centrifug
min
cell
cell
per
mac
buffer
add
fcr
block
reagent
biotin
antibodi
cocktail
per
cell
incub
min
mac
buffer
antibiotin
microbead
per
cell
incub
min
ml
mac
buffer
centrifug
min
cell
cell
per
mac
buffer
wash
magnet
column
ml
mac
buffer
pass
cell
columnrins
column
three
time
ml
mac
buffer
collect
eluat
contain
monocyt
cell
cultur
rpmi
fc
penicillinstreptomycin
gmcsf
gmcsf
ad
everi
differenti
monocytederiv
dc
assess
fac
analysi
neg
dcsignposit
digest
spe
sph
h
linear
dna
purifi
qiaquick
pcr
purif
kit
transcrib
vitro
h
use
rna
polymeras
ui
buffer
contain
rnasin
cap
analog
h
incub
rna
polymeras
ad
mixtur
incub
min
see
note
rna
mix
equal
quantiti
rna
usual
ad
bhk
cell
pb
without
calcium
magnesium
immedi
transfer
electropor
cuvetth
rnacel
mixtur
subject
two
puls
v
biorad
gene
pulser
plate
flask
ml
gmem
medium
contain
fcssupernat
contain
recombin
defect
sfv
particl
harvest
h
later
clear
centrifug
min
room
temperatur
supernat
concentr
ultracentrifug
h
min
pellet
cover
tne
buffer
incub
h
seal
tube
resuspend
viru
store
aliquot
infect
viru
aliquot
activ
chymotrypsin
treatment
chymotrypsin
mm
min
room
temperatur
inhibit
chymotrypsin
activ
aprotinin
ad
activ
aliquot
incub
minfor
infect
bhk
cell
cell
seed
sixwel
plate
h
infect
wash
serumfre
gmem
incub
dilut
viral
particl
gmem
complement
fc
dilut
one
hour
later
ml
gmem
complement
fc
addedat
h
postinfect
cell
wash
serumfre
gmem
medium
fix
cold
methanol
min
follow
three
wash
pbscell
incub
primari
antibodi
direct
solubl
glycoprotein
interest
dilut
pb
h
room
temperatur
overnight
cell
wash
twice
pb
prior
incub
secondari
peroxidaseconjug
antibodi
pb
per
well
min
room
temperatur
cell
wash
three
time
pb
incub
dab
solut
min
rins
three
time
pb
stain
cell
count
micrometr
object
determin
viru
titer
defect
sfv
particl
activ
cell
infect
describ
subhead
see
note
h
postinfect
cell
wash
five
time
serumfre
gmem
elimin
bsa
maintain
serumfre
gmem
protein
product
product
radiolabel
protein
cell
starv
h
serum
methioninecysteinefre
dmem
prior
addit
cystein
methioninesynthesi
protein
continu
h
postinfect
presenc
absenc
ii
inhibitor
dmj
mm
swainsonin
result
product
solubl
glycoprotein
carri
mannos
nglycan
fig
supernat
clarifi
centrifug
min
g
room
temperatur
concentr
see
subhead
item
glycosyl
pattern
protein
produc
verifi
treatment
endoglycosidas
h
endoh
mu
roch
peptid
nglycosidas
f
pngase
f
u
biolab
exampl
given
fig
hiv
bear
mannos
nglycan
hiv
produc
presenc
dmj
swainsonin
sensit
endoh
contrast
pngasef
treatment
allow
complet
deglycosyl
hiv
produc
either
presenc
absenc
inhibitor
molecular
weight
exclus
mannosyl
hiv
inferior
produc
absenc
mannosidas
inhibitor
result
lower
molecular
weight
mannos
residu
compar
complex
glycosyl
bind
assay
perform
plate
use
dcsign
lsignexpress
cell
buffer
acel
pellet
centrifug
min
buffer
replac
viral
glycoprotein
desir
concentr
buffer
abind
carri
h
gentl
agit
unbound
radioact
remov
three
wash
buffer
cell
pellet
resuspend
buffer
prior
addit
scintil
solut
cellassoci
radioact
count
microbeta
trilux
counter
wallac
assess
specif
interact
viral
glycoprotein
dcsign
lsign
cell
preincub
min
mannan
crd
competitor
neutral
antidcsign
mab
anti
lsign
mab
calcium
chelat
edta
mm
dilut
buffer
addit
label
envelop
proteinsfor
intern
assay
protein
bound
parent
dcsignor
lsignexpress
cell
describ
except
buffer
replac
buffer
b
cell
wash
three
time
incub
min
either
cold
buffer
b
preheat
buffer
b
initi
endocytosi
quantifi
glycoprotein
intern
cell
maintain
either
treat
rmpi
contain
mm
edta
mock
treat
order
remov
viral
protein
bound
lectin
cell
surfac
see
fig
cell
wash
resuspend
bind
buffer
prior
addit
optiphas
supermix
solut
activ
count
describ
altern
protocol
see
note
dcsign
lsignexpress
cell
parent
counterpart
cell
expos
viral
particl
h
vari
moi
fscfree
medium
supplement
penicillinstreptomycin
ph
approx
cell
wash
three
time
complet
medium
remov
excess
viru
incub
viral
replic
evalu
later
depend
readout
use
see
note
dcsign
lsignexpress
cell
parent
counterpart
cell
incub
viral
particl
high
moi
h
fcsfree
medium
supplement
penicillinstreptomycin
ph
approx
see
note
cell
expos
viru
wash
extens
cold
pb
remov
unbound
viral
particl
resuspend
complet
medium
cocultur
equal
number
target
cell
plate
viral
transmiss
quantifi
two
later
dcsign
lsignexpress
cell
parent
counterpart
cell
incub
viral
particl
low
moi
insuffici
directli
infect
target
cell
h
immedi
cocultur
target
cell
without
wash
import
control
viral
particl
incub
medium
alon
h
later
transfer
target
cell
assay
permit
determin
viral
particl
bound
dcsign
lsign
remain
infecti
sever
day
protocol
similar
describ
subhead
except
cocultur
target
cell
start
sever
day
exposur
cell
express
dcsign
lsign
viru
multipl
point
test
establish
kinet
viru
protect
cell
express
lectin
human
primari
lsec
express
lsign
difficult
obtain
reason
use
cell
line
express
lsign
describ
gener
monocytederiv
dc
constitut
express
dcsignaltern
sfv
particl
product
bypass
electropor
bhk
cell
env
permit
directli
produc
recombin
protein
code
modifi
sfv
plasmid
altern
protocol
similar
subhead
step
except
amount
env
rna
transfect
doubl
quantiti
rna
electropor
may
requir
adjust
depend
gene
interest
maximum
volum
rna
electropor
next
step
recombin
protein
product
altern
protocol
continu
subhead
step
advantag
product
viral
particl
cell
infect
equal
moi
henc
quantiti
protein
produc
reproduc
direct
electropor
rnath
qualiti
transcrib
rna
verifi
agaros
gel
electrophoresi
transcrib
rna
store
electroporationdefect
sfv
particl
use
moi
vari
adjust
may
requir
depend
gene
interest
number
cell
infect
correl
quantiti
protein
produc
effici
protein
secret
inform
best
product
observ
hcv
envelop
protein
produc
approx
purifi
protein
per
cell
infect
moi
lsignmedi
viral
intern
also
investig
confoc
microscopi
use
purifi
viral
glycoprotein
see
note
whole
virion
hela
cell
express
dcsign
lsign
cell
seed
coverslip
follow
day
cell
incub
viral
glycoprotein
wildtyp
virus
dilut
buffer
b
h
cell
wash
three
time
ice
cold
pb
remov
unbound
materi
shift
differ
time
allow
endocytosi
cell
fix
paraformaldehyd
min
wash
twice
pb
treat
pb
glycin
min
cell
incub
pb
contain
saponin
bsa
min
dcsign
viral
protein
traffick
follow
use
specif
mab
cell
mount
vectashield
contain
dapi
vector
laboratori
imag
zeiss
microscop
use
plan
apochromat
oil
immers
objectiveopt
solubl
glycoprotein
purifi
immunoaffin
tag
peptid
introduc
sequenc
sever
commerci
tag
peptid
avail
flag
tag
peptid
use
readout
specif
viru
studi
gener
use
wildtyp
virus
viral
particl
carri
report
gene
gfp
luc
exampl
hiv
hcv
use
singlecycl
pseudotyp
viral
particl
gener
cotransfect
cell
nl
luc
gfp
hiv
proviru
lack
env
gene
carri
luc
gfp
gene
place
nef
cdna
plasmid
encod
either
hiv
hcv
envelop
protein
viral
replic
evalu
measur
luciferas
activ
cell
lysat
postinfect
use
luciferas
report
assay
kit
promega
victor
luminomet
perkin
elmer
count
gfpposit
cell
fac
dengu
viru
cell
infect
viral
particl
produc
insect
cell
viral
replic
quantifi
flow
cytometri
use
ab
specif
dengu
viru
antigen
exampl
see
ref
lsignexpress
cell
use
infect
tran
infect
viru
studi
allow
evalu
viru
replic
occur
uniqu
target
cell
chapter
press
four
new
studi
publish
concern
interact
dcsign
virus
role
dcsign
hiv
dissemin
